DIH HOLDING US, INC.: Nasdaq/NYSE listing notice — DIH Holding receives Nasdaq deficiency notice for delayed FY2025 10-K filing

DIH HOLDING US, INC.

Notice received July 29, 2025 for failure to timely file Form 10-K for period ended March 31, 2025.
Company has 60 days to file annual report or submit a compliance plan to Nasdaq.
If plan accepted, Nasdaq may grant up to 180 days from due date (Jan 12, 2026) to regain compliance.
No immediate impact on listing or trading of DHAI common stock or DHAIW warrants.
Company is actively working with auditors and advisors to file as soon as possible.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

DIH HOLDING US, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

July 29, 2025, DIH Holding US, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the period ended March 31, 2025 (the “Form 10K”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC. Under Na

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001641172-25-021918

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.